• Skip to main navigation
  • Skip to search
  • Skip to main content
JKU & KUK Research Portal Home JKU & KUK Research Portal Logo
  • Help & FAQ
    • English
    • Deutsch
  • Home
  • Research units
  • Profiles
  • Research output
  • Projects
  • Activities
  • Datasets
  • Prizes
  • Press/Media
No photo of Sabine Altrichter

View Scopus Profile

Sabine Altrichter

Priv.-Doz., DDr.

  • Department of Dermatology and Venereology
  • Clinical Research Institute for Inflammation Medicine
 https://orcid.org/0000-0001-9955-385X
  • Emailsabine.altrichterjkuat
  • Overview
  • Network
  • Research output (59)
  • Projects (3)
  • Activities (17)
  • Prizes (1)

Research output

  • 59 Article

Research output per year

Research output per year

  • COVID-19 Vaccines: Tolerance of Vaccination in Patients with Allergies

    Kogseder, N., Puxkandl, V., Hötzenecker, W. & Altrichter, S., 26 Aug 2025, In: Vaccines. 13, 9, 14 p., 904.

    Research output: Contribution to journal › Article › peer-review

    Open Access
  • Evidence of immunogenic cell death (ICD) and ICD-dependent dendritic cell activation induced by extracorporeal photopheresis in patients with leukaemic forms of cutaneous T-cell lymphoma

    Lackner, A., Burner, T., Huber, M., Dey, S., Aigner, S., Buxhofer-Ausch, V., Geroldinger-Simic, M., Iselin, C., Chang, Y.-T., Tsai, Y.-C., Altrichter, S., Wolf, P., Kimeswenger, S., Guenova, E. & Hoetzenecker, W., 17 Jul 2025, In: British Journal of Dermatology. 193, 2, p. 276-286 11 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
  • Personalized biologic treatments for patients with Darier disease result in varying responses

    Ettinger, M., Burner, T., Lackner, A., Deli, I., Traxler, J., Altrichter, S., Gratz, I. K., Kimeswenger, S., Guenova, E. & Hoetzenecker, W., 16 Sept 2025, (E-pub ahead of print) In: Journal of the European Academy of Dermatology and Venerology. 4 p.

    Research output: Contribution to journal › Article › peer-review

  • Rapid Change in FcεRI Occupancy on Basophils After Venom Immunotherapy Induction

    Puxkandl, V., Aigner, S., Burner, T., Lackner, A., Moñino-Romero, S., Kimeswenger, S., Hoetzenecker, W. & Altrichter, S., 04 Aug 2025, In: International Journal of Molecular Sciences. 26, 15, 16 p., 7511.

    Research output: Contribution to journal › Article › peer-review

    Open Access
  • Validation of the Symptomatic Dermographism Quality of Life Questionnaire (SD-QoL)

    Muñoz, M., Salameh, P., Altrichter, S., Durner, L., Geppert-Steidl, C., Staubach, P., Bernstein, J. A. & Weller, K., 10 Oct 2025, (E-pub ahead of print) In: The Journal of Allergy and Clinical Immunology: In Practice. 25 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
View all 59 research outputs

Projects

  • 1 Active
  • 2 Finished

Projects per year

  • IJAMP: A mechanistic study to determine the influence of topical JAK-Inhibitor Ruxolitinib treatment on mastcell function and standard allergy test performance

    Hötzenecker, W. (Co-PI), Kimeswenger, S. (Researcher) & Altrichter, S. (PI)

    03.07.2025 → 30.04.2027

    Project: Clinical studies › Clinical Study (Funded research)

  • CLOU064A2303B A multicenter, double-blind, placebo-controlled, randomized withdrawal and open-label extension study followed by long-term open-label treatment cycles to assess the efficacy, safety and tolerability of remibrutinib (LOU064) in adult chronic spontaneous urticaria patients who completed the preceding remibrutinib Phase 3 studies

    Bangerl, T. (Researcher), Hötzenecker, W. (Researcher), Altrichter, S. (PI) & Pröll, A. (Researcher)

    07.08.2023 → 31.10.2023

    Project: Clinical studies › Clinical Study (Industry project)

  • A Phase II, Double-blind, Placebo-controlled, Randomized, Dose-ranging, Parallel Group Study to Evaluate the Safety and Efficacy of PHA-022121 Administered orally for Prophylaxis Against Angioedema Attacks in Patients with Hereditary Angioedema due to C1-Inhibitor Deficiency (Type I or Type II)

    Pröll, A. (Researcher), Öllinger, A. (Researcher) & Altrichter, S. (PI)

    15.05.2023 → 21.08.2023

    Project: Clinical studies › Clinical Study (Industry project)

Activities

  • 16 Invited talk
  • 1 Poster presentation

Activities per year

  • Diagnosis of inducible urticaria with the recommended tools

    Altrichter, S. (Speaker)

    15 Jun 2025

    Activity: Talk or presentation › Invited talk › science-to-science

  • Cholinergic Urticaria

    Altrichter, S. (Speaker)

    04 Dec 2024

    Activity: Talk or presentation › Invited talk › science-to-science

  • Typ-II Immunantwort bei dermatologischen Erkankungen jenseits der AD

    Altrichter, S. (Speaker)

    16 Nov 2024

    Activity: Talk or presentation › Invited talk › science-to-science

  • Inducible Urticaria

    Altrichter, S. (Speaker)

    25 Sept 2024

    Activity: Talk or presentation › Invited talk › science-to-science

  • Autoallergie bei chronischer Urtikaria

    Altrichter, S. (Speaker)

    10 Jun 2024

    Activity: Talk or presentation › Invited talk › science-to-science

View all 17 activities

Prizes

  • Skin reaction patterns in cholinergic urticaria

    Altrichter, S. (Recipient), 2024

    Prize: Prize, award or honor

JKU & KUK Research Portal Logo

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2025 JKU & KUK Research Portal, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

Log in to Pure

Impressum

About web accessibility

Report vulnerability

Contact us